{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T12:35:58Z","timestamp":1793968558513,"version":"4.8.0"},"reference-count":31,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2014,8,1]],"date-time":"2014-08-01T00:00:00Z","timestamp":1406851200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["atherosclerosis-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Atherosclerosis"],"published-print":{"date-parts":[[2014,8]]},"DOI":"10.1016\/j.atherosclerosis.2014.05.944","type":"journal-article","created":{"date-parts":[[2014,6,3]],"date-time":"2014-06-03T21:49:18Z","timestamp":1401832158000},"page":"477-482","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":42,"title":["Lipoprotein(a) level and apolipoprotein(a) phenotype as predictors of long-term cardiovascular outcomes after coronary artery bypass grafting"],"prefix":"10.1016","volume":"235","author":[{"given":"Marat V.","family":"Ezhov","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maya S.","family":"Safarova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olga I.","family":"Afanasieva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valery V.","family":"Kukharchuk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergei N.","family":"Pokrovsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.atherosclerosis.2014.05.944_bib1","doi-asserted-by":"crossref","first-page":"2844","DOI":"10.1093\/eurheartj\/ehq386","article-title":"European Atherosclerosis Society Consensus Panel. Lipoprotein(a) as a cardiovascular risk factor: current status","volume":"31","author":"Nordestgaard","year":"2010","journal-title":"Eur Heart J"},{"key":"10.1016\/j.atherosclerosis.2014.05.944_bib2","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1001\/jama.2009.1063","article-title":"Emerging Risk Factors Collaboration. Lipoprotein(a) concentration and the risk of coronary heart disease, stroke, and nonvascular mortality","volume":"302","author":"Erqou","year":"2009","journal-title":"JAMA"},{"key":"10.1016\/j.atherosclerosis.2014.05.944_bib3","doi-asserted-by":"crossref","first-page":"2331","DOI":"10.1001\/jama.2009.801","article-title":"Genetically elevated lipoprotein(a) and increased risk of myocardial infarction","volume":"301","author":"Kamstrup","year":"2009","journal-title":"JAMA"},{"key":"10.1016\/j.atherosclerosis.2014.05.944_bib4","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1111\/j.1699-0463.1963.tb01808.x","article-title":"A new serum type system in men - the Lp(a) system","volume":"59","author":"Berg","year":"1963","journal-title":"Acta. Path. Microbiol. Scand"},{"key":"10.1016\/j.atherosclerosis.2014.05.944_bib5","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1038\/330132a0","article-title":"cDNA Sequence of human apolipoprotein(a) is homologous to plasminogen","volume":"330","author":"MacLean","year":"1987","journal-title":"Nature"},{"key":"10.1016\/j.atherosclerosis.2014.05.944_bib6","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1161\/01.ATV.9.5.579","article-title":"Detection and quantification of lipoprotein(a) in the arterial wall of 107 coronary bypass patients","volume":"9","author":"Rath","year":"1989","journal-title":"Arteriosclerosis"},{"key":"10.1016\/j.atherosclerosis.2014.05.944_bib7","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1161\/01.ATV.9.5.593","article-title":"Quantitation and localization of apolipoproteins [a] and B in coronary artery bypass vein grafts resected at re-operation","volume":"9","author":"Cushing","year":"1989","journal-title":"Arteriosclerosis"},{"key":"10.1016\/j.atherosclerosis.2014.05.944_bib8","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1172\/JCI113093","article-title":"Lp(a) glycoprotein phenotypes: Inheritance and relation to Lp(a)-lipoprotein concentrations in plasma","volume":"80","author":"Utermann","year":"1987","journal-title":"J Clin Invest"},{"key":"10.1016\/j.atherosclerosis.2014.05.944_bib9","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1182\/blood.V82.2.392.392","article-title":"Does apolipoprotein(a) heterogeneity influence lipoprotein(a) effects on fibrinolysis?","volume":"82","author":"Hervio","year":"1993","journal-title":"Blood"},{"key":"10.1016\/j.atherosclerosis.2014.05.944_bib10","doi-asserted-by":"crossref","first-page":"2160","DOI":"10.1016\/j.jacc.2009.10.080","article-title":"Apolipoprotein(a) isoforms and the risk of vascular disease: systematic review of 40 studies involving 58,000 participants","volume":"55","author":"Erqou","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.atherosclerosis.2014.05.944_bib11","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1016\/0002-9149(94)90459-6","article-title":"Influence of serum lipoprotein(a) and homocyst(e)ine levels on graft patency after coronary artery bypass grafting","volume":"74","author":"Eritsland","year":"1994","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.atherosclerosis.2014.05.944_bib12","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1136\/hrt.78.2.131","article-title":"Serum Lp(a) lipoprotein concentration is not associated with clinical and angiographic outcome five years after coronary artery bypass graft surgery","volume":"78","author":"Skinner","year":"1997","journal-title":"Heart"},{"key":"10.1016\/j.atherosclerosis.2014.05.944_bib13","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/S0021-9150(97)00247-5","article-title":"Serum lipids, lipoprotein(a) and apo(a) isoforms in patients with\u00a0established coronary artery disease and their relation to disease and\u00a0prognosis after coronary by-pass surgery","volume":"137","author":"Lind\u00e9n","year":"1998","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2014.05.944_bib14","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1111\/j.1520-037X.2004.3297.x","article-title":"Elevated levels of low-density lipoprotein cholesterol, homocysteine, and lipoprotein(a) are associated with the occurrence of symptomatic bypass graft disease 1 year following coronary artery bypass graft surgery","volume":"7","author":"Harris","year":"2004","journal-title":"Prev Cardiol"},{"key":"10.1016\/j.atherosclerosis.2014.05.944_bib15","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1016\/S0022-5223(03)00365-9","article-title":"Association of lipoprotein(a) excess with early vein graft occlusions in patients undergoing coronary artery bypass surgery","volume":"126","author":"Pokrovsky","year":"2003","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2014.05.944_bib16","first-page":"18","article-title":"Pokrovski\u012d SN. [High level of lipoprotein (a) as a predictor of poor long-term prognosis after coronary artery bypass surgery]","volume":"51","author":"Ezhov","year":"2011","journal-title":"Kardiologiia"},{"key":"10.1016\/j.atherosclerosis.2014.05.944_bib17","first-page":"398","article-title":"Immuno-enzyme assay for lipoprotein(a) measurement","volume":"4","author":"Afanasieva","year":"1995","journal-title":"Bull Experim Biol Med"},{"key":"10.1016\/j.atherosclerosis.2014.05.944_bib18","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1161\/01.ATV.8.3.212","article-title":"Lp(a) phenotyping by immunoblotting with polyclonal and monoclonal antibodies","volume":"8","author":"Kraft","year":"1988","journal-title":"Arteriosclerosis"},{"key":"10.1016\/j.atherosclerosis.2014.05.944_bib19","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1111\/j.1399-0004.1997.tb04342.x","article-title":"Lp(a) lipoprotein level predicts survival and major coronary events in the Scandinavian Simvastatin Survival Study","volume":"52","author":"Berg","year":"1997","journal-title":"Clin Genet"},{"key":"10.1016\/j.atherosclerosis.2014.05.944_bib20","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1046\/j.1365-2796.2002.00997.x","article-title":"Is lipoprotein(a) a predictor for survival in patients with established coronary artery disease? Results from a prospective patient cohort study in northern Sweden","volume":"252","author":"Glader","year":"2002","journal-title":"J Intern Med"},{"key":"10.1016\/j.atherosclerosis.2014.05.944_bib21","doi-asserted-by":"crossref","first-page":"3055","DOI":"10.1194\/jlr.M008961","article-title":"Lipoprotein(a) levels and long-term cardiovascular risk in the contemporary era of statin therapy","volume":"51","author":"Nicholls","year":"2010","journal-title":"J Lipid Res"},{"key":"10.1016\/j.atherosclerosis.2014.05.944_bib22","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1056\/NEJM198411223112101","article-title":"The relation of risk factors to the development of atherosclerosis in saphenous-vein bypass grafts and the progression of disease in the native circulation. A study 10 years after aortocoronary bypass surgery","volume":"311","author":"Campeau","year":"1984","journal-title":"N Engl J Med"},{"key":"10.1016\/j.atherosclerosis.2014.05.944_bib23","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1161\/01.CIR.77.6.1238","article-title":"Serum Lp(a) level as a predictor of vein graft stenosis after coronary artery bypass surgery in patients","volume":"77","author":"Hoff","year":"1988","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2014.05.944_bib24","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1161\/CIRCULATIONAHA.109.911669","article-title":"Ten-year follow-up survival of the Medicine, Angioplasty, or Surgery Study (MASS II): a randomized controlled clinical trial of 3 therapeutic strategies for multivessel coronary artery disease","volume":"122","author":"Hueb","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2014.05.944_bib25","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.atherosclerosis.2011.12.012","article-title":"Non-high-density lipoprotein cholesterol is a practical predictor of long-term cardiac death after coronary artery bypass grafting","volume":"221","author":"Fukushima","year":"2012","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2014.05.944_bib26","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.atherosclerosis.2011.05.039","article-title":"Increased lipoprotein(a) is associated with polyvascular disease in patients undergoing coronary artery bypass graft","volume":"219","author":"Song","year":"2011","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2014.05.944_bib27","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1373\/clinchem.2003.023689","article-title":"Report of the National Heart, Lung, and Blood Institute Workshop on Lipoprotein(a) and Cardiovascular Disease: Recent Advances and Future Directions","volume":"49","author":"Marcovina","year":"2003","journal-title":"Clin Chem"},{"key":"10.1016\/j.atherosclerosis.2014.05.944_bib28","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1161\/01.ATV.12.10.1214","article-title":"Apo(a) isoforms predict risk for coronary heart disease. A study in six populations","volume":"12","author":"Sandholzer","year":"1992","journal-title":"Arterioscler Thromb"},{"key":"10.1016\/j.atherosclerosis.2014.05.944_bib29","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1681\/ASN.V1051027","article-title":"The low molecular weight apo(a) phenotype is an independent predictor for coronary artery disease in hemodialysis patients: a prospective follow-up","volume":"10","author":"Kronenberg","year":"1999","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.atherosclerosis.2014.05.944_bib30","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1016\/j.clinthera.2013.06.006","article-title":"Effects of aggressive statin therapy on patients with coronary saphenous vein bypass grafts: a systematic review and meta-analysis of randomized, controlled trials","volume":"35","author":"Kang","year":"2013","journal-title":"Clin Ther"},{"key":"10.1016\/j.atherosclerosis.2014.05.944_bib31","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.atherosclerosissup.2012.10.014","article-title":"Cascade plasma filtration during the first year after CABG in patients with hyperlipidemia refractory to statins","volume":"14","author":"Ezhov","year":"2013","journal-title":"Atheroscler Suppl"}],"container-title":["Atherosclerosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915014012076?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915014012076?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,4,5]],"date-time":"2022-04-05T17:31:12Z","timestamp":1649179872000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021915014012076"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,8]]},"references-count":31,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014,8]]}},"alternative-id":["S0021915014012076"],"URL":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2014.05.944","relation":{},"ISSN":["0021-9150"],"issn-type":[{"value":"0021-9150","type":"print"}],"subject":[],"published":{"date-parts":[[2014,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Lipoprotein(a) level and apolipoprotein(a) phenotype as predictors of long-term cardiovascular outcomes after coronary artery bypass grafting","name":"articletitle","label":"Article Title"},{"value":"Atherosclerosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2014.05.944","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}